NeoPrediX, a Regensburg, Germany-based predictive analytics company focused on neonatal, maternal, and perinatal health, received an investment from Springhood Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to further accelerate the development and deployment of its solutions aimed at improving outcomes for newborns worldwide.
Led by CEO Thorsten Waloschek, NeoPrediX is a predictive analytics company focused on developing proprietary algorithms to forecast the risk of various health conditions under the neonatal, maternal, and perinatal umbrella. It aims to empower healthcare providers with the tools they need to improve outcomes for newborns and their families.
The company has offices in Switzerland and US.
FinSMEs
12/09/2024